文献速递系统性红斑狼疮

羟氯喹与系统性红斑狼疮妊娠先兆子痫及早产并发症的关联

Hydroxychloroquine Use, Preeclampsia, and Preterm Delivery Complications in Systemic Lupus Erythematosus Pregnancies: Is There a Protective Effect?
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-05-06

该研究基于加拿大不列颠哥伦比亚省围产期数据登记库,纳入597名公开保险的SLE女性共847例单胎妊娠,采用倾向评分校正的修正泊松回归分析。结果显示,与未使用羟氯喹相比,妊娠期使用羟氯喹(≥2次配药或≥60天供应)与先兆子痫/子痫风险无显著关联(校正RR 0.92,95%CI 0.47-1.80),与早产也无显著关联。结论认为早孕期羟氯喹使用未显著降低先兆子痫或早产风险。

要点

  • SLE妊娠中羟氯喹使用与先兆子痫风险无显著关联(校正RR 0.92,95%CI 0.47-1.80)。
  • 不同暴露定义下,羟氯喹与早产风险均无显著关联。
  • 分层分析未发现效应修饰的明显差异。

核心结论

  • SLE患者早孕期使用羟氯喹与先兆子痫或早产风险降低无显著关联。

研究设计与样本

  • 基于人群的队列研究,纳入不列颠哥伦比亚省围产期数据登记库中597名公开保险SLE女性的847例单胎妊娠。
  • 采用倾向评分校正的修正泊松回归估计风险比(RR)及95%置信区间(CI),并对早产进行Cox比例风险模型的时间至事件分析。

主要发现

  • 与无配药相比,妊娠期≥2次配药或≥60天供应的羟氯喹暴露校正RR为0.92(95%CI 0.47-1.80)。
  • 将暴露窗口扩大至孕前三个月,结果相似。
  • 不同早产定义下均未发现显著关联,分层分析未见明显效应修饰差异。

关键数值与推荐

  • 羟氯喹暴露定义包括妊娠20周内≥2次配药或≥60天供应。
  • 主要结局为先兆子痫/子痫和早产。

临床怎么用

  • 对于SLE妊娠患者,不应仅基于预防先兆子痫或早产的目的而常规加用羟氯喹,需结合其他适应证个体化决策。

局限性

  • 需要更大规模队列研究进一步明确羟氯喹与SLE妊娠结局的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) increases the risk of adverse pregnancy outcomes, including preeclampsia and preterm delivery. Hydroxychloroquine (HCQ), widely used to manage SLE, has shown mixed associations with pregnancy outcomes. We investigated the association between HCQ use and risks of preeclampsia/eclampsia and preterm delivery, accounting for maternal covariates in a population-based cohort of SLE pregnancies. METHODS: We studied 847 singleton pregnancies among 597 publicly insured women with SLE in the British Columbia Perinatal Data Registry (mean ± SD maternal age 33.1 ± 4.6 years; 43% nulliparous). SLE was identified before pregnancy, and HCQ exposure during pregnancy was defined using multiple approaches, including ≥2 fills or ≥60 days' supply during the 20 weeks of pregnancy. Modified Poisson regression estimated risk ratios (RRs) and 95% confidence intervals (CIs) using propensity scores to address confounding. Stratified analyses examined effect modification. For preterm delivery, we conducted a time-to-event analysis using a Cox proportional hazards model. Multiple sensitivity analyses explored definitions of SLE, HCQ exposures, and outcomes. RESULTS: Pregnancies with ≥2 fills or ≥60 days' supply compared to no fills had an adjusted RR of 0.92 (95% CI 0.47-1.80). Results were similar when expanding the exposure window to include three months preconception. We found no association across different definitions for preterm delivery. The stratified analyses results showed no appreciable differences. CONCLUSION: Early pregnancy HCQ use in patients with SLE was not significantly associated with reduced risk of preeclampsia or preterm delivery. Further studies with larger cohorts are needed to clarify these associations.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Sediqi S, Lu N, Avina-Zubieta A, et al. Hydroxychloroquine Use, Preeclampsia, and Preterm Delivery Complications in Systemic Lupus Erythematosus Pregnancies: Is There a Protective Effect? Arthritis Care Res (Hoboken). 2026. PMID: 41870006. doi:10.1002/acr.80046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。